| 2012 Run for Our Lives |
|
Thank you to everybody who participated, donated, and volunteered with the 8th annual CIBC Run for Our Lives! This year, we raised just over $100,000 and we're still receiving donations. Money raised through the CIBC Run for Our Lives supports breast cancer programs, services and equipment necessary in the NWT. For information on: Where does the money go...Since 2005, residents of the NWT have raised over one million dollars! Unlike other cancer fundraiser events, the lion’s share of proceeds raised from the CIBC Run for Our Lives stay here in the NWT to benefit residents in the NWT. The program also contributes to research in finding a cure and improving treatment. Funds raised to date have been distributed as follows:
2012 Initiative: Chemotherapy/IV Treatment Suite The Stanton Territorial Hospital is in desperate need of an area dedicated solely to chemotherapy/IV treatments. Currently, the Hospital administers chemotherapy/IV treatments in the Medical Day Care Unit mixed in with several other day treatments and protocols. The Chemotherapy and IV Treatment program has seen a 200% increase in the past 10 years, with over 1,500 patient visits in 2011-2012. The current chemotherapy/IV treatment space has three chemo-chairs, side-by-side, with no privacy curtains. The small space of the Unit often leads to situations which may compromise patient care, comfort, confidentiality, and infection control standards. The point has been reached whereby cancer related treatment services need to be provided in their own space. The major goal of the 2012 CIBC Run for Our Lives is to raise funds to contribute to this project in support of the many breast cancer patients requiring access to chemo/IV therapy at Stanton Territorial Hospital. Continuous Initiative: Patient Navigator Position The cancer patient navigator is a full-time nurse at the Stanton Territorial Hospital who receives 50% of her core funding from the CIBC Run for Our Lives. The cancer patient navigator provides much needed support to patients who are undergoing cancer treatment by:
For more information:Rebecca Alty Patty Olexin-Lang |
